University College London

Creating the bioprocess engineering base for converting research into new medicines


Biochemical Engineering, pioneered at UCL, converts life science discoveries into vaccines, regenerative medicine cures and therapeutic drugs. The research and training has generated a new global industry. Successes include the processes for semi-synthetic penicillin production, the world’s first anti-virals against influenza, and the vaccine for cervical cancer.